Clinical Trials in Detroit

Showing 16401-16420 of 19,719 trials

Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer

NCT01727869

This is an open-label, multicenter, ascending multiple dose study of REGN1400 alone and in combination with erlotinib or cetuximab administered to patients with certain types of cancer.

Cancer

Regeneron Pharmaceuticals56 participantsStarted Oct 2012

Santa Monica, California, United States • Atlanta, Georgia, United States • Detroit, Michigan, United States +3 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication

NCT00117650

The purpose of this Phase 2 clinical research study is to examine the safety of an experimental gene transfer agent, Ad2/HIF-1α/VP16, and its ability to stimulate the growth of new blood vessels from existing blood vessels (a process called angiogenesis) in an attempt to improve the flow of blood in the legs of patients with peripheral arterial disease (PAD). Specifically, this study will enroll patients with severe intermittent claudication (IC) which is the stage of PAD in which a patient's walking ability is severely limited, causing pain in the legs upon exercise due to inadequate blood flow to the muscles of the lower limbs.

Intermittent ClaudicationPeripheral Vascular DiseaseAtherosclerosis

Genzyme, a Sanofi Company289 participantsStarted Feb 2005

Birmingham, Alabama, United States • Palo Alto, California, United States • Sacramento, California, United States +44 more locations

Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer

Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication

Find Trials by Condition in Detroit

Proactive Diabetes Case Management

Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes

Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients

Effect on Weight Loss of Exenatide Versus Placebo

Development and Evaluation of a Hormone Replacement Therapy Decision-Aid

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I

Smoking Cessation for Young Adults Who Binge Drink - 1

Group Visits to Improve Hypertension Management

Fibroid Ablation Study